共 29 条
- [21] Comparison of 3D-conformal Irradiation Technique (3D-cRT) and volumetrically modulated Arc-therapy (VMAT) by using the example of singular Target Volume (ZV) in the Brain - Plan Comparisons in the context of the integral Dose Loading (ID) of the Brain [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 : S62 - S62
- [22] Dosimetric Evaluation of Automated Single-Isocenteric vs. Conventional Multi-Isocenteric SRS Technique Using Dynamic Conformal Arcs for the Treatment of Multiple Brain Metastasis [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E506 - E507
- [23] Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Utilizing Single-Isocenter vs. Multiple-Isocenter Technique [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E84 - E85
- [25] Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients—comparative analysis of dose distribution and estimation of projected secondary cancer risk [J]. Strahlentherapie und Onkologie, 2023, 199 : 90 - 101
- [26] Dosimetric comparison of 2.5 mm vs. 3.0 mm leaf width micro-multileaf collimator-based treatment systems for intracranial stereotactic radiosurgery using dynamic conformal arcs: implications for treatment planning [J]. Japanese Journal of Radiology, 2011, 29 : 630 - 638
- [28] A novel weight optimized dynamic conformal arcs with TrueBeam™ Linac for very small tumors (≤1 cc) with single isocenter of multiple brain metastases (2≤, ≥4) in stereotactic radiosurgery: A comparison with volumetric modulated arc therapy [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1297 - 1304
- [29] Three-dimensional conformal radiotherapy (3D-CRT) vs. volumetric modulated arc therapy (VMAT) in deep inspiration breath-hold (DIBH) technique in left-sided breast cancer patients-comparative analysis of dose distribution and estimation of projected secondary cancer risk [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 (01) : 90 - 101